NCO-700

Overview

NCO-700 is a dual cathepsin B and calcium-activated neutral protease ( CANP ) inhibitor with IC 50 values of 0.8 and 46 μM, respectively. NCO-700 reduces the degradation of myocardial fibrin by inhibiting protease activity. NCO-700 also has inhibitory effects on hormone-independent tumor cells, such as prostate cancer cells, and induces apoptosis . NCO-700 can be used to study myocardial ischemia and refractory hormone-independent tumors.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Breast Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Cathepsin | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-106058
• CAS No.: 84518-80-9
• Molecular Formula: C26H39N3O8
• Molecular Weight: 521.60
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source